FDA approves first once-daily drug for ADHD

CBD cannabis extract may improve social responsiveness and reduce disruptive behavior in children with autism, with no increase in adverse effects, according to a recent study

Each year in this country, physicians prescribe medications to treat ADHD in nearly 3 million children. The safety of these agents has been the subject of some debate.

Results will be included an a final analysis of safety and efficacy data for CTx-1301, which will be included in a NDA submission with the FDA, stated Cingulate Inc.

Parents’ screen habits influence kids' media use, with bedroom and mealtime screen time increasing exposure to mature content.

"My takeaway is that if medicine is needed, stimulants will be my first choice in this age group, regardless of whether the ADHD coexists with ASD."

"In aggregation with other robust observational studies, these results can inform the management of asthma and allergic rhinitis in this patient group," wrote the study authors.